Adamant Health

Finland
Kuopio, North Savo, Finland

Company profile

Adamant Health company profile

Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objective and long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2020-08-24

Headquarters

Country code
FI
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
2
Total equity funding
$2.3M
Last funding
Seed / $2.3M / 2022-06-13
Last equity funding
Seed / $2.3M
Investors
3
Lead investors
1
Founders
2
Articles
1

Founders and investors

Founders

Paulus CarpelanSaara Rissanen

Lead investors

Voima Ventures

Investors

Cor GroupGerresheimer GlasVoima Ventures